Lianghui Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lianghui Li has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Allaka Nagalakshmi
Department of Human Anatomy and Histology, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), 8/2 Trubetskaya Str., Moscow, 119991, Russia; Saveetha Institute of Basic Medical Sciences (SIBMS), Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, Tamil Nadu, India; Department of Molecular Diagnostics and Vaccines, SYENICA Biotech Limited, Chennai (Madras), Tamil Nadu, 602105, India
1 shared publication - Junqi Liu
The Department of Radiation Oncology & Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China
1 shared publication - Qianqian Guo
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, No. 1, Jianshe East Road, Zhengzhou, 450000, China
1 shared publication - Ruixiang Xu
Clinical Medicine of Medical School, Southern University of Science and Technology, No.1088 Xueyuan Avenue, Shenzhen, 518000, China
1 shared publication - Vladimir Nikolaevich Nikolenko
Department of Human Anatomy and Histology I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University) Moscow Russia
1 shared publication - Xiaojing Cui
Department of Oncology, Xiuwu County People's Hospital, No. 55 Ningcheng Avenue, Xiuwu County, Jiaozuo, 454350, China
1 shared publication
Latest Publications
- 9 June 2026
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (8) , 111943
Sex-specific divergence in global urological cancer trajectories to 2050: A dual-model projection analysis based on GLOBOCAN and GBD databases
- 9 June 2026
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 52 (8) , 111943
Sex-specific divergence in global urological cancer trajectories to 2050: A dual-model projection analysis based on GLOBOCAN and GBD databases